For people trapped in the exhausting cycle of chronic urinary tract infections, every new symptom can feel like a setback. Repeated antibiotics, emergency visits, and infections that keep returning can take a serious toll on daily life. Now, a newly FDA-approved fosfomycin injection is offering fresh hope for adults battling complicated urinary tract infections. In clinical testing, this treatment reached about a 64% overall success rate, raising interest among doctors looking for more options against stubborn infections.
